These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29846316)

  • 1. Flibanserin for hypoactive sexual desire disorder in premenopausal women.
    Clements JN; Thompson B
    JAAPA; 2018 Jun; 31(6):51-53. PubMed ID: 29846316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial.
    Katz M; DeRogatis LR; Ackerman R; Hedges P; Lesko L; Garcia M; Sand M;
    J Sex Med; 2013 Jul; 10(7):1807-15. PubMed ID: 23672269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flibanserin Efficacy and Safety in Premenopausal Women With Generalized Acquired Hypoactive Sexual Desire Disorder.
    Fisher WA; Pyke RE
    Sex Med Rev; 2017 Oct; 5(4):445-460. PubMed ID: 28666836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Flibanserin Treatment on Body Weight in Premenopausal and Postmenopausal Women with Hypoactive Sexual Desire Disorder: A Post Hoc Analysis.
    Kornstein SG; Simon JA; Apfel SC; Yuan J; Barbour KA; Kissling R
    J Womens Health (Larchmt); 2017 Nov; 26(11):1161-1168. PubMed ID: 28817365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial.
    Goldfischer ER; Breaux J; Katz M; Kaufman J; Smith WB; Kimura T; Sand M; Pyke R
    J Sex Med; 2011 Nov; 8(11):3160-72. PubMed ID: 21933348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Flibanserin in Women with Hypoactive Sexual Desire Disorder: A Systematic Review and Meta-Analysis.
    Gao Z; Yang D; Yu L; Cui Y
    J Sex Med; 2015 Nov; 12(11):2095-104. PubMed ID: 26745616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flibanserin: First Global Approval.
    Deeks ED
    Drugs; 2015 Oct; 75(15):1815-22. PubMed ID: 26412054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Flibanserin as pharmacological therapy of inhibited sexual desire in women].
    Eldon AS; Giraldi A
    Ugeskr Laeger; 2017 Feb; 179(7):. PubMed ID: 28397671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacodynamic effects of combined administration of flibanserin and alcohol.
    Stevens DM; Weems JM; Brown L; Barbour KA; Stahl SM
    J Clin Pharm Ther; 2017 Oct; 42(5):598-606. PubMed ID: 28608926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action of flibanserin, a multifunctional serotonin agonist and antagonist (MSAA), in hypoactive sexual desire disorder.
    Stahl SM
    CNS Spectr; 2015 Feb; 20(1):1-6. PubMed ID: 25659981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women.
    Dhanuka I; Simon JA
    Expert Opin Pharmacother; 2015; 16(16):2523-9. PubMed ID: 26395164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flibanserin for female sexual dysfunction.
    Reviriego C
    Drugs Today (Barc); 2014 Aug; 50(8):549-56. PubMed ID: 25187905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flibanserin for Premenopausal Hypoactive Sexual Desire Disorder: Pooled Analysis of Clinical Trials.
    Simon JA; Thorp J; Millheiser L
    J Womens Health (Larchmt); 2019 Jun; 28(6):769-777. PubMed ID: 30707049
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study.
    Thorp J; Simon J; Dattani D; Taylor L; Kimura T; Garcia M; Lesko L; Pyke R;
    J Sex Med; 2012 Mar; 9(3):793-804. PubMed ID: 22239862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study.
    Derogatis LR; Komer L; Katz M; Moreau M; Kimura T; Garcia M; Wunderlich G; Pyke R;
    J Sex Med; 2012 Apr; 9(4):1074-85. PubMed ID: 22248038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flibanserin: initial evidence of efficacy on sexual dysfunction, in patients with major depressive disorder.
    Kennedy S
    J Sex Med; 2010 Oct; 7(10):3449-59. PubMed ID: 20646181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flibanserin: From Bench to Bedside.
    Dooley EM; Miller MK; Clayton AH
    Sex Med Rev; 2017 Oct; 5(4):461-469. PubMed ID: 28757356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flibanserin: a potential treatment for Hypoactive Sexual Desire Disorder in premenopausal women.
    Clayton AH; Dennerstein L; Pyke R; Sand M
    Womens Health (Lond); 2010 Sep; 6(5):639-53. PubMed ID: 20887163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Women: A Systematic Review and Meta-analysis.
    Jaspers L; Feys F; Bramer WM; Franco OH; Leusink P; Laan ET
    JAMA Intern Med; 2016 Apr; 176(4):453-62. PubMed ID: 26927498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First Pharmacological Therapy for Hypoactive Sexual Desire Disorder in Premenopausal Women: Flibanserin.
    Robinson K; Cutler JB; Carris NW
    Ann Pharmacother; 2016 Feb; 50(2):125-32. PubMed ID: 26692273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.